| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.18 | 0.007 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.025 | 0.7 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.021 | 0.7 |